Most Popular Stories
- Ben Venue can't say when crucial cancer drug will be available
- Gene study finds tumor-cell flaw possibly vulnerable to Pfizer, AZ cancer meds
- Ben Venue's idled plant triggers 'dire' leukemia-drug shortage
- Novartis dealt another setback to broader Menveo use
- The best of times, the worst of times?
- Pioneering stem cell therapy mends damaged heart tissue in patients
- Karo Bio walks away from Phase III cholesterol drug due to safety risks
- Biogen Idec scores lung disease drug in $562.5M buyout of Stromedix
- Pioneering stem cell therapy mends damaged heart tissue in patients
- GSK studies Chinese remedies to discover new drugs
- Chelsea shares nosedive on FDA's questions about key drug
Webinars
- Webinar: Next Gen Sequencing from FFPE SamplesNext generation sequencing (NGS) technologies hold enormous promise to advance personalize
- Getting the most out of First-in-Human and Early Clinical TrialsIn a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
- Special Studies in Cancer Patients: AME and Cardiac SafetyFierceBiotech Editor John Carroll will moderate an expert panel discussion exploring how c
- Biomarkers and Translational Medicine in Early Phase Oncology Clinical Development (Part two of our three part series) Increasingly, new technologies are making it possible to carefully identify sets of patien
Featured Jobs
-
Manager Business Development
Clinical Resource Network - US West Coast -
Manager, Business Development
Clinical Resource Network - Chicago, IL -
Product Manager, Channel Marketing Job
Celgene Corporation - Summit, NJ, US -
Benefits Specialist Job
Celgene Corporation - Summit, NJ, US -
District Sales Manager – Hematology, Denver / Phoenix Job
Celgene Corporation - Denver, CO, US
Events
- DCAT Week '12 Biologics Forum & Networking Reception
Mar 14 — New York City - BioNetwork East: Key BioPharma Partnering Conference
March 5-7 2012 — Miami, Florida - Just Released: New Trends in Preventive and Therapeutic Vaccine
- Pharmaceutical Strategic Outlook
April 11-13, 2012 — Grand Hyatt, New York
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- Let travelers smell your rich media content
- Strategies for Managing Pharmaceutical Workforce and Site Reductions: Analysis of legal, productivity, and quality control issue
- The 3W Gaurrantee: What you Really Saved when you invest in Outsourced Talent
- Best Practices: ERP Vendor Reference-Checking
- cTQM (Clinical Total Quality Management)
- Launching a Medical Device, Healthcare or Life Science Product: Fail Fast, Marginal or Worth Pursuing?
Agios Pharmaceuticals CEO David Scheinkein
